Sara Thrall, PhD

Senior R&D leader and scientific entrepreneur with 25+ years spanning global pharma discovery (GSK, Roche), strategy consulting (Accenture), startup co-founding (1859), and a deep portfolio of fractional CSO / CEO / SAB engagements with early-stage biotech.

Background in enzymology and discovery-stage drug hunting, with current emphasis on AI-driven drug discovery, in-silico platforms, 'omics, and personalized medicine. Already an active SAB member at Intelisci since April 2024, where she pairs executive search with end-to-end discovery-to-commercial advisory for early-stage biotech clients.

Brings unusual breadth, global pharma at the VP/Site Head level, strategy consulting at MD level, hands-on cofounder experience, and a working network across chemistry, biology, AI/ML, finance, and leadership coaching.